← Scroll for more →
Financial Statements — SGMT
Balance Sheet
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 165.90 | 36.63 | 35.02 | 32.50 | 42.33 | 64.72 | 75.84 | 77.01 | 95.96 | 176.78 | 75.14 | 101.84 | 18.51 |
| Short-term Investments | 74.23 | 67.91 | 78.10 | 84.20 | 83.08 | 79.85 | 75.41 | 75.47 | 70.41 | 16.93 | 19.76 | 0.00 | 0.00 |
| Total Current Assets | 243.99 | 107.72 | 116.40 | 119.48 | 127.20 | 146.07 | 152.77 | 157.19 | 166.75 | 194.49 | 96.65 | 102.82 | 21.35 |
| Total Non-current Assets* | 19.44 | 0.04 | 0.08 | 8.92 | 10.21 | 0.10 | 7.49 | 17.59 | 22.27 | 0.04 | 0.07 | 0.11 | 0.14 |
| Total Assets | 263.43 | 107.76 | 116.48 | 128.40 | 137.41 | 146.17 | 160.26 | 174.78 | 189.02 | 194.53 | 96.72 | 102.93 | 21.50 |
| Accounts Payable | 1.13 | 2.30 | 1.31 | 4.24 | 1.92 | 3.22 | 1.43 | 1.15 | 1.99 | 0.53 | 0.19 | 1.70 | 2.72 |
| Total Current Liabilities | 5.42 | 5.30 | 5.10 | 9.15 | 7.25 | -- | 4.45 | -- | -- | -- | 5.65 | 5.05 | 5.29 |
| Total Non-current Liabilities* | 1.86 | 0.00 | 0.00 | 0.00 | 0.00 | -- | 0.00 | -- | -- | -- | 0.00 | 0.00 | 0.01 |
| Total Liabilities* | 7.28 | 5.30 | 5.10 | 9.15 | 7.25 | 7.18 | 4.45 | 4.09 | 5.73 | 4.51 | 5.65 | 5.05 | 5.29 |
| Retained Earnings | (370.95) | (357.00) | (346.35) | (336.78) | (323.87) | (313.49) | (295.31) | (279.11) | (264.49) | (256.37) | (249.74) | (241.59) | (235.24) |
| Total Stockholder Equity | 256.15 | 102.46 | 111.38 | 119.26 | 130.16 | 138.99 | 155.81 | 170.68 | 183.29 | 190.02 | 91.07 | 97.88 | (198.41) |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | 2.00 | -- |
| Research & Development | 11.54 | 7.00 | 6.73 | 9.73 | 7.25 | 15.34 | 14.22 | 12.65 | 6.31 | 5.26 | 5.66 | 4.96 | 4.68 |
| Selling, General & Admin | 4.28 | 4.72 | 4.03 | 4.60 | 4.68 | 4.52 | 3.98 | 4.25 | 4.28 | 3.51 | 3.81 | 4.49 | 2.38 |
| Total Operating Expenses | 15.82 | 11.71 | 10.77 | 14.33 | 11.93 | 19.86 | 18.20 | 16.90 | 10.59 | 8.77 | 9.47 | 9.45 | 7.06 |
| Operating Income | (15.82) | (11.71) | (10.76) | (14.33) | (11.92) | (19.86) | (18.19) | (16.90) | (10.59) | (8.77) | (9.47) | (7.45) | (7.06) |
| Net Income | (13.95) | (10.65) | (9.57) | (12.91) | (10.39) | (18.18) | (16.20) | (14.62) | (8.12) | (6.63) | (8.15) | (6.35) | (6.78) |
| Basic EPS | (0.26) | (0.33) | (0.30) | (0.40) | (0.32) | (0.56) | (0.52) | (0.45) | (0.25) | (0.23) | 69.07 | (40.34) | (35.80) |
| Diluted EPS | (0.26) | (0.33) | (0.30) | (0.40) | (0.32) | (0.56) | (0.52) | (0.45) | (0.25) | (0.23) | 69.07 | (40.34) | (35.80) |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | (11.10) | (8.61) | (11.83) | (10.18) | (9.10) | (14.54) | (11.02) | (19.57) | (5.63) | (6.21) | (7.08) | (3.88) | (10.80) |
| Investing Cash Flow | (24.02) | 10.22 | 14.36 | 0.08 | (13.29) | 3.41 | 9.85 | 0.62 | (75.16) | 3.00 | (19.62) | 0.00 | 32.20 |
| Financing Cash Flow | 164.39 | -- | 0.00 | 0.27 | 0.00 | -- | 0.00 | 0.00 | (0.03) | 104.85 | 0.00 | 87.21 | (1.05) |
← Scroll for more columns →